Near-Infrared II Fluorescence Imaging and Image-Guided siRNA Therapy of Atherosclerosis
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Jialu Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Renmin Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Atherosclerosis, Optical Imaging, RNA, Small Interfering. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Wuhan University People's Hospital Cross-Innovation Talent Project.
Abstract (Originalsprache)
Targeting Ca2+/calmodulin-dependent protein kinase γ (CaMKIIγ) in macrophages using RNAi nanotechnology represents an innovative and promising strategy in the diagnosis and treatment of atherosclerosis. Nevertheless, it remains elusive because of the current challenges associated with the systemic delivery of siRNA nanoparticle (NP) to atheromatous plaques and the complexity of atherosclerotic plaques. Here, we demonstrate the potential of a thienothiadiazole-based near-infrared-II (NIR-II) organic aggregation-induced emission (AIE) platform encapsulated with the Camk2g siRNA to effectively target CaMKIIγ in macrophages for dynamic imaging and image-guided gene therapy of atherosclerosis. The nanoparticles effectively decreased CaMKIIγ expression and increased the expression of the efferocytosis receptor MerTK in plaque macrophages, leading to a reduction in the necrotic core area of the lesion in an aortic plaque model. Our theranostic approach highlights the substantial promise of near-infrared II (NIR-II) AIEgens for imaging and image-guided therapy of atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Renmin Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430060, China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.
- Key Laboratory of Virology and Biosafety (CAS), Shenzhen Institute of Wuhan University, Shenzhen 518057, China.
- Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430060, China.
ORCID-Profile: Xuechuan Hong
Förderung
- Wuhan University People's Hospital Cross-Innovation Talent Project
Zitieren
APA
Gao, J., Yu, K., Luo, Q., Deng, M., Hou, X., Wang, W., Zeng, X., Xiong, X., He, Y., Hong, X., & Xiao, Y. (2024). Near-Infrared II Fluorescence Imaging and Image-Guided siRNA Therapy of Atherosclerosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01208
Vancouver
Gao J, Yu K, Luo Q, Deng M, Hou X, Wang W, et al. Near-Infrared II Fluorescence Imaging and Image-Guided siRNA Therapy of Atherosclerosis. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01208
BibTeX
@article{Gao2024,
author = {Gao, Jialu and Yu, Kai and Luo, Qiusi and Deng, Mingbo and Hou, Xiaowen and Wang, Wumei and Zeng, Xiaodong and Xiong, Xiaoxing and He, Yong and Hong, Xuechuan and Xiao, Yuling},
title = {Near-Infrared II Fluorescence Imaging and Image-Guided siRNA Therapy of Atherosclerosis},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01208}
}
EUVIMED